10/23/2018

Chlorothiazide Sodium Injection

Reason for the Shortage

- Akorn had chlorothiazide injection on shortage due to manufacturing delays.
- Sagent had chlorothiazide injection on shortage due to increased demand.
- Sun Pharma has chlorothiazide injection available.

Available Products

- Sodium Diuril injection, Akorn, 500 mg, vial, 1 count, NDC 76478-0711-40
- Chlorothiazide injection, Akorn, 500 mg, vial, 1 count, NDC 17478-0419-40
- Chlorothiazide injection, American Regent, 500 mg, vial, 1 count, NDC 00517-1820-01
- Chlorothiazide injection, Fresenius Kabi, 500 mg, vial, 1 count, NDC 63323-0658-20
- Chlorothiazide injection, Mylan Institutional, 500 mg, vial, 1 count, NDC 67457-0263-30
- Chlorothiazide injection, Sagent, 500 mg, vial, 1 count, NDC 25021-0305-20
- Chlorothiazide injection, Sun Pharma, 500 mg, vial, 1 count, NDC 47335-0330-40

Estimated Resupply Dates

- All marketed presentations are available

Updated

Updated October 23, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created December 11, 2017 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.